Revvity, Inc. (NYSE:RVTY) Q4 2023 Earnings Call Transcript February 1, 2024 Revvity, Inc. beats earnings expectations. Reported EPS is $1.25, expectations were $1.15. Revvity, Inc. isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello, and welcome to today’s Revvity Inc. Q4 2023 […]
Revvity, Inc. (NYSE:RVTY) Q3 2023 Earnings Call Transcript November 5, 2023 Operator: Hello, and welcome to the Q3 2023 Revvity Earnings Conference Call. My name is Alex. I’ll be coordinating the call today. [Operator Instructions] I’ll now hand it over to your host, Steve Willoughby, Senior Vice President, Investor Relations. Please go ahead. Steve Willoughby: […]
As it relates to the existing brand architecture, Revvity said its BioLegend, Euroimmun, Tulip Diagnostics and ViaCord franchises will retain their respective names as unique product lines.